The invention describes the use of betaine for treating and preventing arterites. The invention also describes an orally administered composition for treating arterites and, in particular, intermittent claudication, said composition containing, as an active ingredient, an active therapeutic quantity of betaine glycine by single dose. The invention particularly describes a medicament provided for treating a patient suffering from an intermittent claudication caused by peripheral circulatory disorders such as arteriosclerosis obliterans or by thromboangiitis obliterans.

 
Web www.patentalert.com

< Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene

< Indole derivatives

> Polyamine analogs as therapeutic agents for ocular diseases

> Novel compounds

~ 00275